SeaStar Medical: Board & Executive Compensation Changes

Ticker: ICUCW · Form: 8-K · Filed: Aug 19, 2025 · CIK: 1831868

Seastar Medical Holding CORP 8-K Filing Summary
FieldDetail
CompanySeastar Medical Holding CORP (ICUCW)
Form Type8-K
Filed DateAug 19, 2025
Risk Levelmedium
Pages2
Reading Time3 min
Key Dollar Amounts$0.0001, $11.50, $300,000
Sentimentneutral

Sentiment: neutral

Topics: board-changes, executive-compensation, governance

TL;DR

SeaStar Medical shakes up board, adjusts exec pay.

AI Summary

SeaStar Medical Holding Corp. announced on August 13, 2025, changes related to its board of directors and executive compensation. Specifically, the company elected new directors and appointed certain officers, alongside adjustments to compensatory arrangements for its key executives. The filing also mentions the company's common stock and warrants.

Why It Matters

Changes in board composition and executive compensation can signal shifts in company strategy, governance, and future performance expectations.

Risk Assessment

Risk Level: medium — Changes in leadership and compensation can introduce uncertainty regarding future strategic direction and financial performance.

Key Numbers

Key Players & Entities

FAQ

What specific changes were made to the board of directors?

The filing indicates the election of new directors, but the specific names and details of their appointments are not provided in this excerpt.

Were there any new executive appointments?

Yes, the filing states that certain officers were appointed, but their names and specific roles are not detailed in this section.

What is the date of the earliest event reported in this 8-K?

The earliest event reported is dated August 13, 2025.

In which state is SeaStar Medical Holding Corp. incorporated?

SeaStar Medical Holding Corp. is incorporated in Delaware.

What is the primary business address of SeaStar Medical Holding Corp.?

The primary business address is 3513 Brighton Blvd, Suite 410, Denver, Colorado 80216.

Filing Stats: 708 words · 3 min read · ~2 pages · Grade level 13 · Accepted 2025-08-19 16:05:28

Key Financial Figures

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. SeaStar Medical Holding Corporation By: /s/ Eric Schlorff Date: August 19, 2025 Name: Eric Schlorff Title: Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing